T. Gsponer

发表

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy

C. Yiannoutsos, M. Egger, B. Musick, 2012, Sexually Transmitted Infections.

Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis

M. Egger, G. Wandeler, N. Bender, 2012, Tropical medicine & international health : TM & IH.

Non‐ignorable loss to follow‐up: correcting mortality estimates based on additional outcome ascertainment

A. Boulle, M. Fox, M. Schomaker, 2014, Statistics in medicine.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

B. Chi, M. Egger, A. Westfall, 2011, AIDS.

HIV Infection Disrupts the Sympatric Host–Pathogen Relationship in Human Tuberculosis

J. Schrenzel, M. Zwahlen, M. Egger, 2013, PLoS genetics.

Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study

J. Stringer, M. Egger, T. Hallett, 2013, PloS one.

Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa

M. Egger, R. Wood, D. Dickinson, 2013, AIDS.

Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.

H. Günthard, H. Furrer, E. Bernasconi, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

gsbDesign: An R Package for Evaluating the Operating Characteristics of a Group Sequential Bayesian Design

Florian Gerber, Thomas Gsponer, Florian Gerber, 2016 .

A practical guide to Bayesian group sequential designs

Heinz Schmidli, David Ohlssen, Björn Bornkamp, 2014, Pharmaceutical statistics.

Critical aspects of the Bayesian approach to phase I cancer trials

Michael Branson, Beat Neuenschwander, Thomas Gsponer, 2008, Statistics in medicine.

Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study.

M. Egger, M. Battegay, H. Furrer, 2013, The Journal of infectious diseases.

Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References

M. Egger, B. Eley, A. Grimwood, 2015, The Pediatric infectious disease journal.

Growth response to antiretroviral treatment in HIV‐infected children: a cohort study from Lilongwe, Malawi

M. Egger, O. Keiser, H. Tweya, 2010, Tropical medicine & international health : TM & IH.

Variability of Growth in Children Starting Antiretroviral Treatment in Southern Africa

M. Egger, B. Eley, O. Keiser, 2012, Pediatrics.

Reply to letter: "Population-based analysis of 4113 patients with acute cholecystitis: defining the optimal time point for laparoscopic cholecystectomy".

D. Candinas, V. Banz, U. Güller, 2014, Annals of Surgery.

Population-Based Analysis of 4113 Patients With Acute Cholecystitis: Defining the Optimal Time-Point for Laparoscopic Cholecystectomy

D. Candinas, V. Banz, U. Güller, 2011, Annals of surgery.

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

M. Egger, L. Muhe, B. Eley, 2013, PLoS medicine.

The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring

M. Maathuis, B. Chi, M. Petersen, 2012, AIDS.

Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, J. Sterne, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Cohort study of trials submitted to ethics committee identified discrepant reporting of outcomes in publications.

E. von Elm, M. Egger, A. Blümle, 2013, Journal of clinical epidemiology.

Predictors of Clinical Outcomes in Patients With Severe Aortic Stenosis Undergoing TAVI: A Multistate Analysis

Christoph Huber, Balthasar Eberle, Peter Jüni, 2012, Circulation. Cardiovascular interventions.

Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis

Thomas Gsponer, Gilles Wandeler, Matthias Egger, 2012, AIDS.

gems: An R Package for Simulating from Disease Progression Models.

Nello Blaser, Bindu Kalesan, Thomas Gsponer, 2015, Journal of statistical software.

Additive Effect of Anemia and Renal Impairment on Long-Term Outcome after Percutaneous Coronary Intervention

L. Räber, P. Wenaweser, S. Windecker, 2014, PloS one.

Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

Matthias Cavassini, Patrick Taffé, Amalio Telenti, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A phase I study of AMN107 alone and in combination with imatinib in patients (pts) with imatinib-resistant gastrointestinal stromal tumors (GIST).

J. Blay, G. Demetri, M. von Mehren, 2006, Journal of Clinical Oncology.

A practical guide to Bayesian group sequential designs

D. Ohlssen, H. Schmidli, Florian Gerber, 2014, Pharmaceutical statistics.

Growth response to antiretroviral treatment in HIV‐infected children: a cohort study from Lilongwe, Malawi

M. Egger, O. Keiser, H. Tweya, 2010, Tropical medicine & international health : TM & IH.

Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

A. Telenti, M. Egger, R. Weber, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.